29 Dec 2014
(MENAFN) UAE’s RAK Ceramics, the world’s largest ceramics manufacturer, announced that its subsidy in Bangladesh is planning to sell RAK Pharma, its pharmaceutical interest, as the company proceeds in its plan to offload its asset to focus more on its core business of ceramics production, Emirates 24/7 reported.
RAK Ceramics said that its Bangladesh unit currently has a 55 percent stake in RAK Pharma, with expectations that that company will sell its entire stock of RAK Pharma shares, while the other shares will be sold by minority shareholders, with the entire sale estimated to be valued at USD9.5 million.
“The decision to sell RAK Pharma was taken for two reasons. Firstly, our strategy is to focus on our core activities; tiles, sanitary ware, taps and faucets and tableware. In addition, RAK Pharma is currently a loss-making division so it makes good business sense to sell it at this time,” CEO, RAK Ceramics said.
The RAK Ceramics also said that the Bangladesh unit is planning to increase its capacity of tiles and sanitary ware production in Bangladesh and that the expansion is already underway, and is scheduled to be done in 2015.
01 Mar 2026
BBK activates partial remote working system for its workforce to ensure employee and customer safety and service continuity
24 Feb 2026
BBK discloses its financial results for the year ended 31st December 2025
05 Feb 2026
BBK announces December Al Hayrat Grand Prize winners and another wave of Grand prizes for February
26 Jan 2026
BBK Enhances Autumn Fair 2026 Experience with Customized Rewards and Premium Services
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more